Principal Financial Group
CNST

Principal Financial Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Principal Financial Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,048
Closed -$373K – 2657
2021
Q2 		$373K Buy
11,048
+492
+5% +$12.5K ﹤0.01% 2286
2021
Q1 		$247K Sell
10,556
-7,191
-41% -$218K ﹤0.01% 2333
2020
Q4 		$512K Buy
+17,747
New +$447K ﹤0.01% 2106
2020
Q3 		– Sell
-8,888
Closed -$267K – 2376
2020
Q2 		$267K Buy
+8,888
New +$320K ﹤0.01% 2115

Principal Financial Group's CNST Position: Q3 2021 in Review

Principal Financial Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 11,048 shares — an estimated $373K sold.

Principal Financial Group first reported a position in CNST in Q2 2020 and held it in 4 quarters. The position peaked at $512K in Q4 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Principal Financial Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Principal Financial Group sold 11,048 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $373K.
  • Principal Financial Group first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 4 quarters.
  • Principal Financial Group's Constellation Pharmaceuticals, Inc. position peaked at $512K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Principal Financial Group's 13F filing for Q3 2021, filed 9 Nov 2021.